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Background: Increased muscle mass index of the left ventricle (LVMi) is an independent predictor for the
development of symptoms in patients with asymptomatic aortic stenosis (AS). While the onset of clinical symptoms
and left ventricular systolic dysfunction determines a poor prognosis, the standard echocardiographic evaluation of LV
dysfunction, only based on measurements of the LV ejection fraction (EF), may be insufficient for an early assessment of
imminent heart failure. Contrary, 2-dimensional speckle tracking (2DS) seems to be superior in detecting subtle changes
in myocardial function. The aim of the study was to assess these LV function deteriorations with global longitudinal
strain (GLS) analysis and the relations to LVMi in patients with AS and normal EF.
Methods: 50 patients with moderate to severe AS and 31 controls were enrolled. All patients underwent
echocardiography, including 2DS imaging. LVMi measures were performed with magnetic resonance imaging in 38
patients with AS and indexed for body surface area.
Results: The total group of patients with AST showed a GLS of -15,2 ± 3,6% while the control group reached -19,5
± 2,7% (p < 0,001). By splitting the group with AS in normal, moderate and severe increased LVMi, the GLS was
-17,0 ± 2,6%, -13,2 ± 3,8% and -12,4 ± 2,9%, respectively (p = 0,001), where LVMi and GLS showed a significant
correlation (r = 0,6, p < 0,001).
Conclusions: In conclusion, increased LVMi is reflected in abnormalities of GLS and the proportion of GLS
impairment depends on the extent of LV hypertrophy. Therefore, simultaneous measurement of LVMi and GLS
might be useful to identify patients at high risk for transition into heart failure who would benefit from aortic valve
replacement irrespectively of LV EF.
Background
The therapeutic management of patients with aortic ste-
nosis (AS) depends on the severity of the stenosis and
the presence of symptoms or the presence of left ventri-
cular (LV) dysfunction, since the onset of symptoms and
LV dysfunction determines a poor prognosis [1,2].
Particularly, patients with LV dysfunction show signifi-
cantly worse outcome [3]. Notably, left ventricular dys-
function may develop insidiously in the asymptomatic
patient.
The pathophysiological starting point in the develop-
ment of subclinical LV dysfunction in AS is still a mat-
ter of debate. LV hypertrophy is a very common finding
in AS and can result in early impairment in the LV per-
formance. In order to compensate the elevated wall
stress, the LV wall thickness increases, maintaining
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any medium, provided the original work is properly cited.normal ejection fraction (EF) [4]. As there are two sides
to every coin, LV hypertrophy is beneficial in some
respects and harmful in other. In subjects with asympto-
matic AS, increased left ventricular mass index (LVMi)
was found to be an independent predictor for the devel-
opment of symptoms in asymptomatic patients with
severe AS [5]. Thus, the challenge for the clinician is to
detect subtle LV contractile dysfunction at an early sub-
clinical stage so that closer follow ups can be instituted
or aortic valve replacement (AVR) can be performed to
prevent irreversible LV deterioration. Recent guidelines
only focus on LV EF to define systolic function. Never-
theless, since EF is based solely on endocardial radial
motion, LV dysfunction may be underestimated by the
standard parameter EF. Tissue Doppler imaging [6] and
2-dimensional strain (2DS) analysis of longitudinal myo-
cardial function are superior in detecting subtle dete-
riorations of contractility [7]. In particular, analysis of
global longitudinal strain (GLS) is a novel index for the
assessment of global LV function and subtle deteriora-
tions [8-10]. Hence, simultaneous measurement of
LVMi and longitudinal myocardial function can provide
new insights into the mechanical adaptation of the LV
to chronic afterload elevation.
In the present study, we hypothesized that an
increased LVMi in subjects with moderate to severe AS
is reflected in abnormalities in GLS and that the propor-
tion in GLS impairment depends on the extent of LV
hypertrophy. In addition, we investigated whether GLS
is sensitive enough to detect early recovery of global
myocardial function after AVR.
Methods
This study was planned for patients with moderate to
severe AS who underwent conventional and 2 D speckle
tracking echocardiography as part of clinical trial proto-
col. A total of 50 patients were enrolled. The study pro-
tocol was approved by the local ethics committee.
Magnetic resonance imaging (MRI) was performed to
assess LVMi and LV function. Exclusion criteria were
concomitant mitral valve disease, severe low gradient
AS, EF < 35%, hypertrophic obstructive cardiomyopathy,
uncontrolled hypertension, severe ventricular arrhyth-
mias, and general exclusion criteria for MRI.
Standard and tissue Doppler echocardiography were
done with a commercially available system (Vingmed
Vivid 7, General Electric, Milwaukee, Wisconsin). LV EF
was calculated by the biplane Simpson’sm e t h o d .L e f t
ventricular mass index was obtained by normalizing
LVMi to body surface area according [11]. Doppler
assessment of AS included the measurement of the peak
and mean pressure gradient (Pmax and Pmean) and the
transvalvular velocity (Vmax). Aortic valve area (AVA)
was calculated by means of the continuity equation and
indexed for body surface area (BSA); and pressure
recovery adjusted aortic valve area (i.e. energy loss
index, ELI) was calculated by a previously validated for-
mula [12]. Severe AS was defined as AVA index < 0,6
cm
2/m
2 with a Pmean ≥ 40 mmHg.
Deformation analysis of the datasets was performed off-
line using EchoPac PC8.0 (General Electric-Vingmed). For
this purpose, recordings of 3 consecutive 2 D images were
used to analyze regional deformation on grey-scale images
recorded from the parasternal LV short-axis (at the level
of papillary muscles and LV apex) and apical four-, two-
and three chamber views, respectively. The cardiac cycle
with the best image quality and without any artefacts was
selected for reporting results. Strain and strain rate analy-
sis was performed as described previously [13]. In brief,
the endocardial border was manually traced at an end-sys-
tolic frame. The software then automatically detected the
frame-to-frame motion of the natural ultrasound reflecting
markers (speckles). The position of myocardial speckles
followed the longitudinal, radial and circumferential direc-
tion of motion. Aortic valve closure was identified from
the continuous wave Doppler recording of the aortic valve
flow. Results were reported as the peak during systole
(peak systolic strain and peak systolic strain rate). Longitu-
dinal measurements from the individual three apical stan-
dard views were averaged to obtain a GLS strain value [9].
The average peak radial systolic strain values were
obtained from the parasternal short axis view at the level
of the LV apex.
A 1.5-Tesla Achieva MRI scanner (Philips Medical
Systems, Netherlands) equipped with a 5-element car-
diac synergy coil was used. Cine-Images were acquired
in breath hold SSFP sequences (TE 3.43, TR 1.72).
Images were evaluated with the cmr42 research edition
toolkit (circle cardiovascular imaging, Calgary, Canada)
combining long and short axis views. The program cal-
culated end- and endsystolic volumes, as well as stroke
volume, ejection fraction and finally LVMi. Subjects
were subsequently subdivided into three groups accord-
ing the LVMi [11]: group 1 with normal LVMi, group 2
with mildly increased LVMi and group 3 with moder-
ately or severely increased LVMi [11].
All analyses were performed using SPSS statistical
software (SPSS 17.0, Chicago, IL). The data is presented
as mean ± SD unless otherwise specified. An p < 0.05
was set considered statistically significant. Comparison
of the 2 groups of subjects for various parameters was
performed by 1-way analysis of variance (ANOVA).
Pearson’s linear correlation coefficients were calculated
for pairs of continuous variables. We first analyzed asso-
ciations without any adjustments and then with adjust-
ments for potential confounders by multiple linear
regression for continuous and logistic regression for
categorical variables.
Dinh et al. Cardiovascular Ultrasound 2010, 8:29
http://www.cardiovascularultrasound.com/content/8/1/29
Page 2 of 8Results
Study population
50 patients with moderate to severe aortic stenosis and
31 controls without valvular heart disease and with nor-
mal EF were included. In 12 subjects with AS, either MRI
or 2DS measurements was not performed because of bad
image quality, low frame rate or claustrophobia. There-
fore, both MRI measurements of LVMi and echocardio-
graphic determination of GLS were done in 38 subjects.
The baseline demographics and clinical characteristics
are highlighted in table 1. Clinical characteristics did not
differ between the different degrees of LVMi and con-
trols. The presence of concomitant CAD was identified
by angiography in 66% of patients with AS and in 45% of
controls and was lower in patients with normal LVMi
compared to those with mildly increased LVMi (p =
0,03), but not compared to those with moderately or
severe increased LVMi (p = 0,85). The average logistic
EuroSCORE was 11,1% and the additive EuroSCORE 7,2
in the study group, respectively.
Echocardiographic and MRI measurements
Echocardiographic and MRI measurement results are
summarized in Table 2. According to the indexed aortic
v a l v ea r e a( A V A ) ,3 2( 8 4 % )p a t i e n t sw e r ec l a s s i f i e da s
having severe aortic stenosis (AVAindex < 0,6 cm/m2),
whereas 6 (16%) subjects were identified with moderate
AS (AVAindex 0,6-0,85 cm/m2). Left ventricular muscle
mass measurement reveals a normal LVMi in 64% of
subjects with AS (group 1), whereas increased LVMi
was detected in 44% of the study group: 26% with mildly
i n c r e a s e dL V M i( g r o u p2 )a n d1 8 %w i t hm o d e r a t e l yo r
severely increased LVMi (group 3). The echocardio-
graphic image quality was sufficient to analyze longitudi-
nal myocardial strain in 96% of patients included. In
addition, GLS values were obtained in the control
group. One-way ANOVA analysis demonstrated that the
total group of patients with AST had significantly
reduced GLS values (-15,2 ± 3,6%), compared to con-
trols (-19,5 ± 2,7% p < 0,001). By splitting subjects with
AS in group 1,2 or 3, the GLS was -17,0 ± 2,6%, -13,2 ±
3,8% and -12,4 ± 2,9%, respectively (Fig. 1, p = 0,001).
The post-hoc analysis showed a significant difference
between group 1 vs. group 2 (p = 0,008) and between
g r o u p1a n dg r o u p3( p=0 , 0 0 4 )a n dL V M ia n dG L S
correlated significantly (Fig. 2, r = 0,6, p < 0,001) in the
whole study group.
AVA, Pmean or EF did not differ between groups 1-3,
respectively. In a multiple linear regression analysis
including age, gender, hypertension, CAD, EF, history of
myocardial infarction or history of coronary bypass sur-
gery, AVAindex and Pmean, only LVMi remain a signif-
icant predictor variable for GLS impairment (Beta =
0,42, p = 0,009). Left ventricular EF (determined with
MRI) and GLS (r = -0,42, p = 0,14) or LVMi (r = -0,30,
p = 0,06) were not correlated.
The average peak radial systolic strain values (PRS)
obtained from the parasternal short axis view at the
Table 1 Demographics, clinical and laboratory characteristics














Age (mean ± SD) 73 ± 9 69 ± 10 0,08 75 ± 5 70 ± 11 70 ± 15 0,31
Woman 42% 52% 0,29 48% 30% 42% 0,64




Hx of MI 10% 36% 0,01* 5% 20% 14% 0,41
Hx of CABG 5% 10% 0,37 5% 0% 14% 0,42
Diabetes mellitus 34% 20% 0,15 27% 40% 43% 0,72
Hypertension 87% 92% 0,38 90% 80% 85% 0,72
Hyperlipidemia 53% 83% 0,01* 47% 60% 57% 0,8
Smoking 16% 57% 0,001 14% 10% 29% 0,56
ACE-inhibitor 66% 58% 0,34 62% 60% 85% 0,48
b-Blockers 76% 74% 0,52 81% 70% 71% 0,75
Statins 50% 64% 0,18 38% 50% 85% 0,41
CRP (mg/dl) 0,94 0,99 0,91 1,1 0,6 1,1 0,85




Creatinine (mg/dl) 1,08 1,07 0,92 1,07 1,08 1,09 0,99
ACE = angiotensine converting enzyme, CAD = coronary artery disease, dl = deciliter; Hx = history of, LVM = left ventricular muscle mass index, mg = milligram,
MI = myocardial infarction, n.d. = not done, SD= standard deviation, ↑ = increased, * = significant (p < 0,05)
Dinh et al. Cardiovascular Ultrasound 2010, 8:29
http://www.cardiovascularultrasound.com/content/8/1/29
Page 3 of 8level of the LV apex were tended to be higher in sub-
jects with mildly increased LVMi compared to normal
LVMi or moderately to severe increased LVMi (49,1 vs.
35,4 vs. 34,9%, p = 0,38).
A follow up visit at 3 month was done in 15 subjects. The
average GLS values improved from -15,2 ± 3,6 to -17,6 ±
3,2%. All patients irrespectively of LVMi shows an augmen-
tation of GLS (group 1 from -17,0 ± 2,6 to -19,5 ± 2,8%;
group 2 from -13,2 ± 3,8 to -15,4 ± 2,4%; group 3 from
-12,4 ± 2,9 to -15,8%, Fig. 3). Nevertheless, GLS was still
reduced in subjects with mildly or moderately increased
LVMi compared to controls (-19,5 vs. -15,4, p = 0,01).




Normal (n = 21)
LVM
mildly increased (n = 10)
LVM
considerably
increased (n = 7)
p- Value
LVM (MRI, g/m
2 BSA, SD) 101 ± 23 84 ± 12 116 ± 11 131 ± 14
LVM (Echo, g/m
2 BSA, SD) 121 ± 36 103 ± 29 132 ± 31 161 ± 23
GLS Baseline (%) -15,2 ± 3,6 -17,0 ± 2,6 -13,2 ± 3,8 -12,4 ± 2,9 0,001*
GLS after AVR (%) -17,6 ± 3,2 -19,5 ± 2,8 -15,4 ± 2,4 -15,8 0,04*
Vmax (cm/s) 434 ± 71 428 ± 72 426 ± 64 462 ± 80 0,51
Pmax (mmHg) 77 ± 26 75 ± 26 74 ± 22 87 ± 30 0,5
Pmean (mmHg) 45 ± 18 43 ± 17 43 ± 16 53 ± 22 0,37
AVA (cm
2) 0,86 ± 0,23 0,89 ± 0,18 0,87 ± 0,26 0,73 ± 0,32 0,32
AVA index (cm
2/m
2 BSA) 0,47 ± 0,12 0,49 ± 0,08 0,46 ± 0,12 0,42 ± 0,21 0,41
ELI (cm
2/m
2 BSA) 0,54 ± 0,16 0,56 ± 0,11 0,53 ± 0,15 0,48 ± 0,28 0,49
E/A 1,1 ± 0,8 1,0 ± 0,5 1,1 ± 0,9 1,4 ± 1,3 0,53
Smax (cm/s) 4,8 ± 1,3 5,1 ± 1,3 4,7 ± 1,4 4,0 ± 1,0 0,14
E’ (cm/s) 4,5 ± 1,2 4,9 ± 1,2 3,8 ± 1,2 4,5 ± 1,2 0,06
E/E’ 20,5 ± 8,6 20,6 ± 8,8 21,5 ± 9,9 18,5 ± 6,5 0,78
CO (Echo, l/min) 5,0 ± 2,1 4,9 ± 2,3 5,3 ± 2,5 4,7 ± 0,9 0,85
SV (MRI, ml/min) 86 ± 22 84 ± 24 90 ± 23 85 ± 14 0,77
EF (Echo, %) 64 ± 12 67 ± 8 60 ± 15 61 ± 15 0,23
EF (MRI, %) 64 ± 10 68 ± 7 57 ± 12 63 ± 9 0,16
Left ventricular mass index was graduated based on MRI measurements.
A = late mitral inflow velocity; AVA = aortic valve area; AVR = aortic valve replacement; BSA = body surface area; CO = cardiac output, E = early mitral inflow
velocity; E’ = early tissue Doppler velocity at the septal mitral annuls, EF = ejection fraction; ELI = energy loss index; GLS = global longitudinal strain; LVM = left
ventricular mass index; MRI = magnetic resonance imaging, P = pressure; S = systolic tissue Doppler velocity at the septal mitral annulus); SV = stroke volume;
V = velocity
Figure 1 GLS in relation to left ventricular mass index in controls and patients with aortic stenosis. The range of average peak
longitudinal strain in subjects with normal (group 1), mildly increased (group 2) and moderately to severe (group 3) increased LVMi and aortic
stenosis, controls and the whole study group (n = 38). Left ventricular mass measurements indexed for body surface area were done with MRI. P
= 0,001 for comparison between three groups by full-factorial Anova analysis of variance. #
1 P = 0,008 between average peak longitudinal strain
in group 1 vs. group 2 and #
2 p = 0,004 between the group1 and group 2 by the Bonferroni post hoc test, respectively. *p < 0,001. GLS =
global longitudinal strain, LVMi = left ventricular mass index.
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To our knowledge, this is the first study to report a sig-
nificant relationship between echocardiographic analysis
of GLS and the degree of increased LVMi measured
with MRI techniques. Our study adds several interesting
findings adding to current knowledge on the pathophy-
siology of heart failure development in patients with AS.
Primarily, the extent of LV hypertrophy was indepen-
dently associated with lower GLS, irrespectively of pres-
sure gradients, coronary artery disease (CAD), EF or the
severity of AS. In particular, in this study population,
patients with more advantaged stages of LV hypertrophy
had the lowest average GLS, demonstrating that this
type of hypertrophy is characterized by low myocardial
function. Secondly, impaired myocardial function can be
detected by global myocardial longitudinal function
assessment but not by LV EF measurements. Finally,
GLS improved after AVR three month after surgery.
From the pathophysiological point of view, these
observations are consistent with the concept that pres-
sure overload results in extensive LV remodeling leading
to hypertrophy, keeping wall stress normal. Since wall
stress is a key determinant of ejection performance, its
normalization is important in maintaining a normal EF.
Because the EF is based solely on endocardial radial
motion, the EF tends to increase relating to the extent
of LV hypertrophy in early stages. In our study, radial
strain, as a measurement of radial contraction [14], was
preserved or even increased in subjects with mildly
increased LVMi compared to those with normal LVMi
or severely increased LVMi. Therefore, in early stages of
LV hypertrophy, radial function acts as a compensatory
phenomenon to the decrease in longitudinal deforma-
tion to maintain a normal LV ejection fraction [15].
Furthermore, it was shown that patients with LV
hypertrophy have an increased incidence of cardiac
events, including fatal ones [16]. Despite the fact that
LV hypertrophy helps to preserve EF, it also impairs
coronary blood flow reserve, which first occurs in the
subendocardial layers and is associated with increased
mortality [16,17]. It should be emphasized that the
Figure 2 Average global longitudinal strain (%) plotted against
left ventricular mass index. Average global longitudinal strain (%)
plotted against left ventricular mass index shows a moderate,
significant correlation (r = 0,6; p < 0,01). MRI = Magnetic resonance
imaging.
Figure 3 GLS in relation to left ventricular mass index after aortic valve replacement. The range of average peak longitudinal strain before
and after AVR in subjects with normal (group 1), mildly abnormal (group 2) and moderately to severe (group 3) increased left ventricular mass
index and aortic stenosis, controls and the whole study group (n = 38). GLS = peak longitudinal strain, AVR = Aortic valve replacement,
LVM = left ventricular mass index.
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well as the consecutive reduction in myocardial blood
flow occurs mainly in the subendocardium. The suben-
docardial myocardial fibers are oriented longitudinally.
Thus, the selective impairment in longitudinal myocar-
dial kinetics observed in our study might be due to the
increase in subendocardial wall stress and associated
ischemia and consecutive fibrosis. Hildick-Smith et al.
showed in a previous study that coronary flow reserve
increases after AVR, and this increase occurs in tandem
with regression of LV hypertrophy [18].
Nevertheless, until now, the relation of GLS impair-
ment to the extent of LV hypertrophy has not yet been
clearly established. Echocardiographic imaging is the
most widely available clinical tool to detect LV hypertro-
phy, as determined by the calculated LVMi. A major
limitation of previous studies investigating the associa-
tion between LVMi and GLS is the fact that the repro-
ducibility of LVMi measurement by echocardiographic
techniques is still controversial and prone to imaging
artefacts. Therefore, MRI is a more precise and reliable
method to quantify the mass of the left ventricle [6].
MRI is considered the ideal method for the determina-
tion of LVMi because of its high spatial resolution, gen-
erally good image quality, and ability to reconstruct the
shape of the heart in three dimensions [19]. Therefore,
we performed LVMi measurements with MRI [6] and
GLS with 2 D echocardiography because of its higher
temporal resolution and angle independency [13]. Com-
bining the advantages of both methods, we believe that
our results are robust with minor measurement
artefacts.
Previous studies demonstrated that longitudinal strain
measurement is superior to other indices of LV systolic
function to predict symptoms, exercise tolerance and
outcomes in AS patients [20,21]. Consequently, analysis
of deformation in the longitudinal direction provides the
most powerful approach to unmask subtle myocardial
dysfunction that is not detected by EF in early stages.
Even so, EF is the only index that is included in the
recent guidelines to identify LV systolic dysfunction, a
class I indication for AVR. In the SEAS trial [22], one
third of asymptomatic patients with AS and preserved
EF had a significant impairment of myocardial function.
Hence, EF cannot exclude the presence of intrinsic myo-
cardial dysfunction.
Additionally our study showed that GLS improved an
average by - 2,5% 3 month after AVR, which previous
studies confirmed as well [23,24]. After AVR, cardiac
afterload decreases in relation to a decrease in LV pres-
sure overload. Over time, the LV adapts to the new
loading condition with a regression of hypertrophy and
improvement of LV longitudinal strain. Notably, the EF
did not show any significant changes [25]. Therefore, in
the first instance, the longitudinal myocardial function
improves [26]. Accordingly, 2DS assessment of GLS may
provide a sensitive tool to detect improvement of myo-
cardial function early after AVR.
In summary, our results demonstrate that the associa-
tion between average GLS and LVMi is independent of
age, CAD, severity of AS and LV EF. Because of the
relationship between LV hypertrophy and subtle LV dys-
function, our findings may help to explain why con-
centric LV hypertrophy has been associated with higher
in-hospital mortality after aortic valve replacement [27].
This is of practical importance since today’s guidelines
include only LV EF in management decisions in patients
with AS [1]. These finding justifies the assessment of
GLS in patients with AS because GLS helps to identify
patients the transition from compensatory hypertrophy
to myocardial failure.
Study limitations
There are several limitations to our study. First, MRI
determination of LVMi was not done in controls and
either GLS or MRI was not possible in 12 subjects with
AS. Nevertheless, the control group only serves to pro-
vide a basis for the measurements of GLS values in sub-
jects without AS and comparable age and co-morbidities
like CAD or hypertension. Furthermore, the study popu-
lation was heterogeneous including subjects with or
without concomitant coronary artery disease (CAD).
However, CAD is a very frequent associated co-morbid-
ity in AS and therefore our study population is reflect-
ing clinical daily routine. Additionally, to date only 15
patients have been followed up, and LVMi was only
measured with echocardiography at follow up visit.
However, even statistically arguable, the overage
improvement of GLS is consistent with reported litera-
ture and shows the appropriateness of 2DS analysis in
the detection of subtle improvements early after AVR.
Lastly, antihypertensive treatment was not standardized
and left to the decision of the general practitioners
managing the individual patients. Thus, impact of anti-
hypertensive treatment on deformation parameters
could not be assessed in the study.
Conclusions
Our findings provide new insights into the mechanical
adaptation of the LV to chronic afterload elevation and
its response to unloading. In patients with AS, increased
LVMi is associated with a progressive reduction in GLS
assessed by 2DS. The degree of hypertrophy parallels
the severity of overload, and GLS improves after AVR.
However, left ventricular hypertrophy does not necessa-
rily imply myocardial dysfunction. Therefore, assessment
of GLS can identify subtle contractile dysfunction trig-
gered by increased LV mass and might be useful to
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A V R .T h ep r o g n o s t i ci m p l i c a t i o n so fo u rf i n d i n g s
remain to be assessed in future longitudinal studies.
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